Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (31-40 of 290) with videos related to

Pageof 29
Sort By:
Acta Neurologica Scandinavica|March 1, 1990
Making a diagnosis in patients with an isolated spinal cord syndromeH A Van der Eerden, J C Koetsier, C H Polman
Neurology|October 10, 2007
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyC H Polman, F Deisenhammer, G Giovannoni, et al.
Journal of Neuroimmunology|May 1, 1986
Immunohistological analysis of macrophages in the central nervous system of Lewis rats with acute experimental allergic encephalomyelitisC H Polman, C D Dijkstra, T Sminia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 22, 2012
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MSLvae Bosma, J J Kragt, C H Polman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 16, 1999
Treatment recommendations for interferon-beta in multiple sclerosisC H Polman, D H Miller, W I McDonald, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 24, 2004
[Medicinal cannabis for diseases of the nervous system: no convincing evidence of effectiveness]J Killestein, P M Bet, A C van Loenen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosisM J Eikelenboom, J Killestein, B M J Uitdehaag, et al.
Annals of Neurology|December 24, 1997
Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR imagesF Barkhof, J H van Waesberghe, B M Uitdehaag, et al.
Acta Neurologica Scandinavica|September 1, 1986
Mononuclear cell subpopulations in cerebrospinal fluidC H Polman, C J de Groot, T Sminia, et al.
Journal of Neuroimmunology|July 1, 1994
Functional defects in peripheral blood T cells of multiple sclerosis patients. Diminished in vitro responsiveness in accessory cell dependent activation systemsM H Rep, R Q Hintzen, C H Polman, et al.
Pageof 29

Showing results (31-40 of 290) with videos related to

Sort By:
Pageof 29
Acta Neurologica Scandinavica|March 1, 1990
Making a diagnosis in patients with an isolated spinal cord syndromeH A Van der Eerden, J C Koetsier, C H Polman
Neurology|October 10, 2007
Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyC H Polman, F Deisenhammer, G Giovannoni, et al.
Journal of Neuroimmunology|May 1, 1986
Immunohistological analysis of macrophages in the central nervous system of Lewis rats with acute experimental allergic encephalomyelitisC H Polman, C D Dijkstra, T Sminia, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 22, 2012
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MSLvae Bosma, J J Kragt, C H Polman, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 16, 1999
Treatment recommendations for interferon-beta in multiple sclerosisC H Polman, D H Miller, W I McDonald, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 24, 2004
[Medicinal cannabis for diseases of the nervous system: no convincing evidence of effectiveness]J Killestein, P M Bet, A C van Loenen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 1, 2005
Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosisM J Eikelenboom, J Killestein, B M J Uitdehaag, et al.
Annals of Neurology|December 24, 1997
Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR imagesF Barkhof, J H van Waesberghe, B M Uitdehaag, et al.
Acta Neurologica Scandinavica|September 1, 1986
Mononuclear cell subpopulations in cerebrospinal fluidC H Polman, C J de Groot, T Sminia, et al.
Journal of Neuroimmunology|July 1, 1994
Functional defects in peripheral blood T cells of multiple sclerosis patients. Diminished in vitro responsiveness in accessory cell dependent activation systemsM H Rep, R Q Hintzen, C H Polman, et al.
Pageof 29